These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 8478137
1. Proliferation, migration and invasion of human glioma cells exposed to antifolate drugs. Terzis AJ, Fiskerstrand T, Refsum H, Ueland PM, Arnold H, Bjerkvig R. Int J Cancer; 1993 Apr 22; 54(1):112-8. PubMed ID: 8478137 [Abstract] [Full Text] [Related]
2. Effects of photodynamic therapy on glioma spheroids. Terzis AJ, Dietze A, Bjerkvig R, Arnold H. Br J Neurosurg; 1997 Jun 22; 11(3):196-205. PubMed ID: 9231006 [Abstract] [Full Text] [Related]
4. Effects of DFMO on glioma cell proliferation, migration and invasion in vitro. Terzis AJ, Pedersen PH, Feuerstein BG, Arnold H, Bjerkvig R, Deen DF. J Neurooncol; 1998 Jan 22; 36(2):113-21. PubMed ID: 9525811 [Abstract] [Full Text] [Related]
5. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate. Takemura Y, Ohnuma T. Mt Sinai J Med; 1992 Oct 22; 59(5):419-24. PubMed ID: 1435841 [Abstract] [Full Text] [Related]
15. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas. Tysnes BB, Haugland HK, Bjerkvig R. Invasion Metastasis; 1997 Oct 22; 17(5):270-80. PubMed ID: 9876221 [Abstract] [Full Text] [Related]
16. Release of replication-deficient retroviruses from a packaging cell line: interaction with glioma tumor spheroids in vitro. Thorsen F, Visted T, Lehtolainen P, Ylä-Herttuala S, Bjerkvig R. Int J Cancer; 1997 May 29; 71(5):874-80. PubMed ID: 9180159 [Abstract] [Full Text] [Related]
17. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein. Westerhof GR, Rijnboutt S, Schornagel JH, Pinedo HM, Peters GJ, Jansen G. Cancer Res; 1995 Sep 01; 55(17):3795-802. PubMed ID: 7641196 [Abstract] [Full Text] [Related]
18. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines. Liani E, Rothem L, Bunni MA, Smith CA, Jansen G, Assaraf YG. Int J Cancer; 2003 Feb 20; 103(5):587-99. PubMed ID: 12494465 [Abstract] [Full Text] [Related]
19. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Jansen G, Westerhof GR, Kathmann I, Rademaker BC, Rijksen G, Schornagel JH. Cancer Res; 1989 May 01; 49(9):2455-9. PubMed ID: 2706633 [Abstract] [Full Text] [Related]
20. In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate. van der Laan BF, Jansen G, Kathmann GA, Westerhof GR, Schornagel JH, Hordijk GJ. Int J Cancer; 1992 Jul 30; 51(6):909-14. PubMed ID: 1639538 [Abstract] [Full Text] [Related] Page: [Next] [New Search]